15154660

Source:http://linkedlifedata.com/resource/pubmed/id/15154660

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15154660	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0006142	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0043210	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C1556094	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0935916	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0232970	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C2603343	lld:lifeskim
pubmed-article:15154660	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:15154660	pubmed:issue	2C	lld:pubmed
pubmed-article:15154660	pubmed:dateCreated	2004-5-24	lld:pubmed
pubmed-article:15154660	pubmed:abstractText	Fulvestrant ('Faslodex') is a new type of oestrogen receptor (ER) antagonist that down-regulates the ER and has no known agonist effects.	lld:pubmed
pubmed-article:15154660	pubmed:language	eng	lld:pubmed
pubmed-article:15154660	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15154660	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15154660	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15154660	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15154660	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15154660	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15154660	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15154660	pubmed:issn	0250-7005	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:OhnoShinjiS	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:NomuraYasuoY	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:WatanabeToruT	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:DEVEFF	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:SanoMuneakiM	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:MorrisCharles...	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:NishimuraReik...	lld:pubmed
pubmed-article:15154660	pubmed:author	pubmed-author:ShinEiseiE	lld:pubmed
pubmed-article:15154660	pubmed:issnType	Print	lld:pubmed
pubmed-article:15154660	pubmed:volume	24	lld:pubmed
pubmed-article:15154660	pubmed:owner	NLM	lld:pubmed
pubmed-article:15154660	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15154660	pubmed:pagination	1275-80	lld:pubmed
pubmed-article:15154660	pubmed:dateRevised	2004-11-17	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:meshHeading	pubmed-meshheading:15154660...	lld:pubmed
pubmed-article:15154660	pubmed:articleTitle	Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study.	lld:pubmed
pubmed-article:15154660	pubmed:affiliation	National Cancer Centre Hospital, 5-1-i, Tsukiji, Chuo-ku, Tokyo, Japan. watanabe-oncology@iuhw.ac.jp	lld:pubmed
pubmed-article:15154660	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15154660	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:15154660	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed